Published in Mutat Res on March 11, 2003
Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther (2009) 1.56
Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne) (2013) 1.47
The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol (2006) 1.33
Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer (2014) 1.24
Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells. J Biol Chem (2011) 1.11
Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase. Cancer Res (2010) 1.04
Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem Toxicol (2011) 1.03
Resveratrol oligomers for the prevention and treatment of cancers. Oxid Med Cell Longev (2014) 1.03
Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J Gastroenterol (2003) 0.99
SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells. Front Cell Neurosci (2012) 0.97
Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells. Growth Factors (2007) 0.94
Immortalization of epithelial progenitor cells mediated by resveratrol. Oncogene (2007) 0.92
Resveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell development. PLoS One (2012) 0.92
Resveratrol sensitizes tamoxifen in antiestrogen-resistant breast cancer cells with epithelial-mesenchymal transition features. Int J Mol Sci (2013) 0.88
Resveratrol depletes mitochondrial DNA and inhibition of autophagy enhances resveratrol-induced caspase activation. Mitochondrion (2012) 0.87
SIRT1 promotes RGC survival and delays loss of function following optic nerve crush. Invest Ophthalmol Vis Sci (2013) 0.86
Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia. Ann Hematol (2010) 0.85
Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice. Food Chem Toxicol (2006) 0.85
Oxidative stress and benefits of antioxidant agents in acute and chronic hepatitis. Hepat Mon (2012) 0.84
Transient transfection of a wild-type p53 gene triggers resveratrol-induced apoptosis in cancer cells. PLoS One (2012) 0.81
Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells. Asian J Androl (2009) 0.81
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget (2016) 0.81
Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cells. Growth Factors (2006) 0.80
The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK. Int J Cancer (2008) 0.79
Treatment of FANCA cells with resveratrol and N-acetylcysteine: a comparative study. PLoS One (2014) 0.78
Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts. Calcif Tissue Int (2010) 0.78
In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells. Sci Rep (2016) 0.77
Resveratrol improves salivary dysfunction in a non-obese diabetic (NOD) mouse model of Sjögren's syndrome. J Clin Biochem Nutr (2016) 0.75
The molecular mechanisms of arsenic-induced cell transformation and apoptosis. Environ Health Perspect (2002) 1.10